Adverse pregnancy outcomes and cardiovascular risk factor management

Area of Science:

• Women's Health
• Cardiovascular Disease Epidemiology
• Preventive Cardiology

Background:

• Cardiovascular disease (CVD) is the primary health concern for American women.
• Established risk factors include hypertension, hyperlipidemia, diabetes, smoking, and obesity.
• Adverse pregnancy outcomes (APOs) such as pre-eclampsia, eclampsia, and gestational diabetes are emerging risk factors for future CVD.

Purpose of the Study:

• To highlight the link between adverse pregnancy outcomes and future cardiovascular disease (CVD) risk in women.
• To emphasize the disproportionate CVD risk burden in women of low socioeconomic status and ethnic/racial minorities.
• To advocate for early diagnosis and treatment of CVD risk factors in women, leveraging obstetrician/gynecologist visits.

Main Methods:

• Review of current understanding of CVD risk factors in women.
• Integration of adverse pregnancy outcomes as significant CVD risk indicators.
• Proposal for embedding preventive care providers within OB/GYN settings.
• Reference to American Heart Association (AHA)/American Stroke Association (ASA) guidelines for postpartum CVD risk assessment.

Main Results:

• Adverse pregnancy outcomes are recognized as crucial indicators of future cardiovascular disease (CVD) risk.
• Women of lower socioeconomic status and ethnic/racial minorities face a disproportionately higher CVD risk burden.
• Obstetrician/gynecologist visits present a key opportunity for early CVD risk factor identification and intervention.

Conclusions:

• The medical community must establish practical strategies for assessing and managing CVD risk factors in women.
• Integrating preventive care within OB/GYN practices and establishing clear referral pathways are essential.
• Postpartum evaluation for hypertension and other CVD risk factors is recommended for women with a history of pre-eclampsia, within 6 months to 1 year.